Resources for your patients
Download to support your patients with their treatment experience.
RYBREVANT® + LAZCLUZE™ Patient Brochure–1L EGFR+
A general guide to RYBREVANT® + LAZCLUZE™ for the first treatment of NSCLC with common EGFR+ mutations.
Patient Treatment Journal
A notebook designed for an individual to track their treatment plan and journey.
Patient Affordability Options for RYBREVANT® + LAZCLUZE™
Discover options that may help make RYBREVANT® in combination with LAZCLUZE™ more affordable for your patients. Download this resource to help your patients learn about cost support options.
Patient Affordability Options for RYBREVANT®
Discover options that may help make RYBREVANT® more affordable for your patients. Download this resource to help your patients learn more about cost support options.
RYBREVANT® + Chemotherapy Patient Brochure
A general guide to RYBREVANT® + chemotherapy for the second treatment of NSCLC with EGFR exon 19 deletions or L858R mutations and the first treatment of NSCLC with EGFR exon 20 insertion mutations.
Once you have made the clinical decision to prescribe a RYBREVANT® regimen, Johnson & Johnson has resources to help you support your patients.